Recombinant HDAC2 anticorps

N° du produit ABIN7798931

Cet anticorps Lapin Monoclonal détecte spécifiquement HDAC2 dans WB et FACS. Il présente une réactivité envers Humain.

Aperçu rapide pour Recombinant HDAC2 anticorps (ABIN7798931)

Antigène: HDAC2 (Histone Deacetylase 2 (HDAC2))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp HDAC2 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS)

Classe de qualité: KD Validated

Clone: 25GB2110

Détail du produit anti-HDAC2 anticorps

Expression System: HEK-293 Cells

Fonction: KD-Validated Histone deacetylase 2 Recombinant Rabbit mAb

Réactivité croisée: Souris, Rat

Purification: Affinity Purified

Immunogène: A synthesized peptide derived from human HDAC2

Isotype: IgG

Information d'application

Indications d'application: Western blotting (WB): 1:2,000-1:10,000, Flow Cytometry (FCM): 1:200-1:2,000

Commentaires:

We assess the antibodies’ specificity and selectivity using knockdown techniques. Our validation approach is straightforward: if an antibody identifies a signal in wild-type (WT) cells, but this signal is absent or noticeably reduced in gene-silenced (KD) cells, we consider the antibody to be highly specific.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, pH 7.4, with 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20 °C for one year.

Date de péremption: 12 months

Détails sur HDAC2

Antigène: HDAC2 (Histone Deacetylase 2 (HDAC2))

Autre désignation: Histone deacetylase 2

Poids moléculaire: 55 kDa

ID gène: 3066

UniProt: Q92769

Pathways: Neurotrophin Signaling Pathway, Regulation of Muscle Cell Differentiation, Negative Regulation of intrinsic apoptotic Signaling, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2